Understanding Highlighting A Subset Of Tnbc For Targeted Therapy
Exploring Highlighting A Subset Of Tnbc For Targeted Therapy reveals several interesting facts. Adrian Harris, MD, DPhil, from the University of Oxford, Oxford, UK, speaks at the 2018 National Cancer Research Institute (NCRI) ...
Key Takeaways about Highlighting A Subset Of Tnbc For Targeted Therapy
- Peter Schmid, MD, PhD, FRCP, Barts Cancer Institute, London, UK gives an outline of
- Joyce O'Shaughnessy, MD,
- Adam Brufsky, MD, PhD, of the University of Pittsburgh Medical Center. Pittsburgh, PA, tells us about the progress we are seeing ...
- Triple-negative breast cancer
- Triple Negative Breast Cancer
Detailed Analysis of Highlighting A Subset Of Tnbc For Targeted Therapy
The advent of anti-PD-L1 immunotherapies have significantly improved the treatment landscape of Tiffany A. Traina, MD, a medical oncologist at Weill Cornell Medicine, discusses the current treatment landscape for patients with ... Dr Gregory Vidal, MD, PhD from West Cancer Center
Panelists Adam M. Brufsky, MD, PhD; Kimberly L. Blackwell, MD; Mark E. Robson, MD; and Aditya Bardia, MD, MPH,
Stay tuned for more updates related to Highlighting A Subset Of Tnbc For Targeted Therapy.
